IGI Laboratories Inc

Type: Company

Name: IGI Laboratories Inc

First reported May 10 2013 - Updated May 10 2013 - 2 reports

Manufacturing

IGI Laboratories Q1 net loss narrows

IGI Laboratories, Inc., a topical generic drug development and manufacturing company, has reported that net loss for the first quarter ended March 31, 2013 was $257,000, or $0.01 loss per share, compared to a net loss of $735,000, or $0.02 loss per share, ... [Published Individual.com - May 10 2013]

Entities: IGI Laboratories Inc, Manufacturing, Generic Drug

First reported May 05 2013 - Updated May 05 2013 - 1 reports

New York Stock Exchange

IGI Laboratories Upgraded by Ativo Research to Unfavorable (IG)

IGI Laboratories (NYSE: IG)Shares of IGI Laboratories (NYSE: IG) opened at 2.01 on Friday. IGI Laboratories has a 52 week low of $0.94 and a 52 week high of $2.03. The stock?s 50-day moving average is currently $1.57. The company?s market cap is $86.3 ... [Published American Banking News - May 05 2013]

Entities: IGI Laboratories Inc, New York Stock Exchange, Cosmetics

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

IGI Laboratories' CEO Discusses Q1 2013 Results - Earnings Call Transcript

IGI Laboratories, Inc. ( IG ) Q1 2013 Earnings Call April 24, 2013 04:30 pm ET Executives Jason Grenfell-Gardner – President & Chief Executive Officer Jenniffer Collins – Chief Financial Officer Analysts Frank Gerardi – Univest Management ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 26 2013]

Entities: IGI Laboratories Inc, Private Securities Litigation Reform Act

First reported Apr 09 2013 - Updated Apr 09 2013 - 2 reports

FDA Food & Drug Administration

IGI Laboratories Reports Tenth ANDA Submission [Manufacturin. . .

IGI Laboratories Reports Tenth ANDA Submission [Manufacturing Close - Up]ProQuest Information & LearningIGI Laboratories, Inc. announced it has submitted its second abbreviated new drug application (ANDA) in 2013 to the US FDA, which brings the company's ... [Published Equities.com - Apr 09 2013]

Entities: IGI Laboratories Inc, FDA Food & Drug Administration, ProQuest Company, New Drug Application

First reported Mar 20 2013 - Updated Mar 20 2013 - 1 reports

8-K - IGI LABORATORIES, INC (0000352998) (Filer)

Filed: 2013-03-20 AccNo: 0000950156-13-000022 Size: 1 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits ... [Published SEC Filings - Mar 20 2013]

Entities: IGI Laboratories Inc, 8-k

First reported Dec 27 2012 - Updated Dec 27 2012 - 1 reports

8-K - IGI LABORATORIES, INC (0000352998) (Filer)

Filed: 2012-12-27 AccNo: 0000950156-12-000088 Size: 47 KBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 9.01: Financial Statements and Exhibits ... [Published SEC Filings - Dec 27 2012]

Entities: IGI Laboratories Inc, 8-k

Quotes

IGI's President and CEO, Jason Grenfell-Gardner, stated, "The launch of our first ever IGI labeled topical pharmaceutical products has enabled us to more than double revenue compared to the first quarter of 2012. We believe that we are one step closer to our mission to become a leading player in the generic topical prescription drug market. At the same time, through the increase in orders from our pharmaceutical partners we were able to grow our formulation and manufacturing contract services revenue 24% over the first quarter of 2012. We believe that our sales strategy to increase revenue and improve our product mix resulted in an increase in gross profit to 30.1% in the first quarter of 2013, from 25.4% in the same period last year."

IGI Laboratories Q1 net loss narrows [Published Individual.com - May 10 2013]

Jason Grenfell-Gardner, President and CEO of the Company, commented, "With this submission, we remain on target to deliver on our expectation to file at least six ANDAs in 2013. The fourth quarter of 2013 will mark the three year anniversary of our first two submissions to the FDA, and based on the FDA's current average review time of thirty-two months, we are hopeful we could receive our first ANDA approval in 2013. Our team has filed ten ANDAs in just over two years. We believe that our successful expansion of our development pipeline is the foundation of our strategy to create long term shareholder value. We will continue to look for opportunities to accelerate the growth of our product portfolio through both our research and business development efforts."

IGI Laboratories Reports Tenth ANDA Submission [Manufacturin. . . [Published Equities.com - Apr 09 2013]

...Jason Grenfell-Gardner, President and CEO of the Company, commented, "With this submission, we remain on target to deliver on our expectation to file at least six ANDAs in 2013. The fourth quarter of 20"

IGI Laboratories, Inc. Announces Tenth ANDA Submission [Published Business Wire Science: Science News - Apr 04 2013]

...Jason Grenfell-Gardner, President and CEO of the Company, commented, "Our first ANDA was submitted to the US FDA in September of 2010, so in less than twenty-eight months we have successfully submitted nine"

IGI Laboratories, Inc. Announces Ninth ANDA Submission [Published EON Health & Medicine - Jan 28 2013]

More Content

sort by: Date \| Relevance
IGI Laboratories Q1 net loss narrows [Published Individual.com - May 10 2013]
IGI Laboratories Q1 net loss narrows [Published Zecco - May 10 2013]
InvestorsGuru.com 46 Filtered Mid-Day Market Mo... [Published StockHouse USA - May 05 2013]
IGI Laboratories Upgraded by Ativo Research to ... [Published American Banking News - May 05 2013]
IGI Laboratories' CEO Discusses Q1 2013 Results... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 26 2013]
IGI Laboratories Announces 1st Quarter 2013 Res... [Published Business Wire Manufacturing News - Apr 25 2013]
IGI Laboratories Announces 1st Quarter 2013 Res... [Published Business Wire Health News - Apr 25 2013]
IGI Laboratories Announces 1st Quarter 2013 Res... [Published Business Wire Science: Science News - Apr 25 2013]
IGI Laboratories to Hold Conference Call for 1s... [Published Business Wire Retail News - Apr 11 2013]
IGI Laboratories to Hold Conference Call for 1s... [Published Business Wire Manufacturing News - Apr 11 2013]
IGI Laboratories to Hold Conference Call for 1s... [Published Business Wire Health News - Apr 11 2013]
IGI Laboratories Reports Tenth ANDA Submission ... [Published Equities.com - Apr 09 2013]
IGI Laboratories Reports Tenth ANDA Submission [Published Individual.com - Apr 09 2013]
IGI Laboratories to Present at 12th Annual Need... [Published Business Wire Retail News - Apr 05 2013]
IGI Laboratories to Present at 12th Annual Need... [Published Business Wire Manufacturing News - Apr 05 2013]
IGI Laboratories to Present at 12th Annual Need... [Published Business Wire Health News - Apr 05 2013]
IGI Laboratories, Inc. Announces Tenth ANDA Sub... [Published Business Wire Science: Science News - Apr 04 2013]
IGI Laboratories, Inc. Announces Tenth ANDA Sub... [Published Business Wire Retail News - Apr 04 2013]
IGI Laboratories, Inc. Announces Tenth ANDA Sub... [Published Business Wire Health News - Apr 04 2013]
8-K - IGI LABORATORIES, INC (0000352998) (Filer) [Published SEC Filings - Mar 20 2013]
8-K - IGI LABORATORIES, INC (0000352998) (Filer) [Published SEC Filings - Mar 05 2013]
IGI Laboratories Announces 4th Quarter 2012 and... [Published EON Health & Medicine - Mar 05 2013]
IGI Laboratories Announces 4th Quarter 2012 and... [Published Business Wire Retail News - Mar 05 2013]
IGI Laboratories Announces 4th Quarter 2012 and... [Published Business Wire Manufacturing News - Mar 05 2013]
IGI Laboratories Announces 4th Quarter 2012 and... [Published Business Wire Health News - Mar 05 2013]
IGI Laboratories to Present at 25th Annual ROTH... [Published EON Health & Medicine - Feb 27 2013]
IGI Laboratories to Present at 25th Annual ROTH... [Published Business Wire Retail News - Feb 27 2013]
IGI Laboratories to Present at 25th Annual ROTH... [Published Business Wire Manufacturing News - Feb 27 2013]
IGI Laboratories to Present at 25th Annual ROTH... [Published Business Wire Health News - Feb 27 2013]
IGI Laboratories to Hold Conference Call for 4t... [Published EON Health & Medicine - Feb 20 2013]

Press Releases

sort by: Date \| Relevance
IGI Laboratories Announces 1st Quarter 2013 Res... [Published Business Wire Manufacturing News - Apr 25 2013]
IGI Laboratories Announces 1st Quarter 2013 Res... [Published Business Wire Health News - Apr 25 2013]
IGI Laboratories Announces 1st Quarter 2013 Res... [Published Business Wire Science: Science News - Apr 25 2013]
IGI Laboratories to Hold Conference Call for 1s... [Published Business Wire Retail News - Apr 11 2013]
IGI Laboratories to Hold Conference Call for 1s... [Published Business Wire Manufacturing News - Apr 11 2013]